Pharmacy Trends
What Benefit Advisors Should Tell Their Clients About Discount Drug Programs
From Transparency to Gold Carding, 5 PBM State Regulation Trends from ’23
Appeals Court Decision Favoring PCMA Leaves Questions for ERISA Plans
10 Fast Facts About the Pharmacy Benefits Industry
Protecting Your Clients Against Off-Label Ozempic
Biosimilars, GLP-1s, and Stop-loss: Topics Benefit Advisors Need to Consider in Q3 2023
Everything you need to know about 340B in 2023
The 5 Most Expensive Gene Therapies in the U.S.
Get Our Newsletter
Stay informed with expert advice and actionable insights to optimize pharmacy benefits, reduce costs and enhance member care.
